For research use only. Not for therapeutic Use.
Octahydroaminoacridine succinate, a Tacrine analogue, is an acetylcholinesterse (AChE) and butyrylcholinesterase (BChE) inhibitor. Octahydroaminoacridine succinate can be used for Alzheimer’s disease (AD) research[1].
| Catalog Number | I008399 |
| CAS Number | 866245-79-6 |
| Synonyms | butanedioic acid;1,2,3,4,5,6,7,8-octahydroacridin-9-amine |
| Molecular Formula | C17H24N2O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C13H18N2.C4H6O4/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;5-3(6)1-2-4(7)8/h1-8H2,(H2,14,15);1-2H2,(H,5,6)(H,7,8) |
| InChIKey | SXNZJEKZKUJFLV-UHFFFAOYSA-N |
| SMILES | C1CCC2=C(C1)C(=C3CCCCC3=N2)N.C(CC(=O)O)C(=O)O |
| Reference | [1]. Jiangbin Han, et al. Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2009 Sep 8;50(2):171-4. |
